TG and neoplasm: 18FDG-PET/CT revealed a reduction in tumour size and SUVmax (Fig. 5C, Ca to Cd) as well as a decrease in Tg level to 9123 ng/mL in 3 months after the combination therapy with RAI and apatinib.